TG Therapeutics Investigational Trial Site

Roeland Park, Kansas 66205

1 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) — Recruiting now